These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20042977)

  • 1. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
    Mascarenhas J; Azevedo A; Bettencourt P
    Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD predicts mortality in HF: the Norwegian Heart Failure Registry.
    De Blois J; Simard S; Atar D; Agewall S;
    J Card Fail; 2010 Mar; 16(3):225-9. PubMed ID: 20206897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
    Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
    J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistent chronic obstructive pulmonary disease-heart failure: mechanisms, diagnostic and therapeutic dilemmas.
    Chhabra SK; Gupta M
    Indian J Chest Dis Allied Sci; 2010; 52(4):225-38. PubMed ID: 21302600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
    Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
    Egred M; Shaw S; Mohammad B; Waitt P; Rodrigues E
    QJM; 2005 Jul; 98(7):493-7. PubMed ID: 15955798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland.
    Hawkins NM; Jhund PS; Simpson CR; Petrie MC; Macdonald MR; Dunn FG; Macintyre K; McMurray JJ
    Eur J Heart Fail; 2010 Jan; 12(1):17-24. PubMed ID: 19951962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
    Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
    J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure and chronic obstructive pulmonary disease: An ignored combination?
    Rutten FH; Cramer MJ; Lammers JW; Grobbee DE; Hoes AW
    Eur J Heart Fail; 2006 Nov; 8(7):706-11. PubMed ID: 16531114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure and COPD: partners in crime?
    Hannink JD; van Helvoort HA; Dekhuijzen PN; Heijdra YF
    Respirology; 2010 Aug; 15(6):895-901. PubMed ID: 20546188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease].
    Di Tano G; Frattini S; Pirelli S
    G Ital Cardiol (Rome); 2011 Sep; 12(9):588-95. PubMed ID: 21892219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
    Bułdak Ł; Duława A; Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Sirak TE; Jelic S; Le Jemtel TH
    J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-blockers in patients with COPD.
    Andrus MR; Holloway KP; Clark DB
    Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure.
    Rusinaru D; Saaidi I; Godard S; Mahjoub H; Battle C; Tribouilloy C
    Am J Cardiol; 2008 Feb; 101(3):353-8. PubMed ID: 18237599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.